NAFLD fibrosis score is associated with high-risk coronary plaque in patients with NAFLD
- Author:
- No author available
- Journal Title:
- Chinese Journal of Health Management
- Issue:
- 2
- DOI:
- 10.3760/cma.j.cn115624-20210527-00297
- Key Word:
- 动脉粥样硬化;冠状动脉疾病;非酒精性脂肪性肝病;脂肪肝纤维化评分;Atherosclerosis;Coronary artery disease;Non-alcoholic fatty liver disease;Non-invasive fibrosis score
Abstract： Objective:To investigate the possible role of non-invasive fibrosis scoring systems for detecting high-risk plaque among patients with non-alcoholic fatty liver disease (NAFLD).Methods:A total of 477 consecutive asymptomatic subjects underwent a health checkup including coronary computed tomography angiography (CTA) and abdominal ultrasonography. Fatty liver was evaluated using ultrasonography, and the NAFLD fibrosis score (NFS) was calculated. Coronary stenosis and plaque were evaluated using coronary CTA.Results:Of the study population, 223 had NAFLD. Among the NAFLD patients, high-risk coronary plaque was more frequent in patients with high or intermediate NFS than those with low NFS (62.5% versus 24.0%, P<0.001). The adjusted odds ratio with 95% confidence interval of high-risk plaque was 3.24 (1.11-9.40) for the highest versus lowest quartile of NFS ( P=0.016). Among those without NAFLD, NFS was not associated with high-risk coronary plaque (C-statistic with NFS versus without NFS, 0.766 versus 0.764, P=0.715). Adding NFS to the traditional cardiovascular disease (CVD) risk model increased the C-statistics by 0.679 to 0.739 ( P=0.031). Conclusions:There was an independent association of NFS with high-risk coronary plaque in patients with NAFLD, suggesting its potential use to optimize management of patients with NAFLD.
- [1]中华医学会肝病学分会脂肪肝和酒精性肝病学组,中国医师协会脂肪性肝病专家委员会.非酒精性脂肪性肝病防治指南（2018更新版）[J].2018,(3).
- [2]Gi-Ae Kim,Han Chu Lee,Jaewon Choe,etc.Association between non-alcoholic fatty liver disease and cancer incidence rate[J].2018,68(1).
- [3]吴有禾,宋震亚.非酒精性脂肪性肝病的血清学评估方法[J].2020,(4).
- [4]Chang,Y.,Jung,H.-S.,Yun,K.E.,etc.Cohort study of non-alcoholic fatty liver disease, nafld fibrosis score, and the risk of incident diabetes in a korean population[J].2013,108(12).
- [5]Scott M, Grundy,H Bryan, Brewer,James I, Cleeman,etc.Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition.[J].2004,109(3).
- [6]Puchner,S.B.,Liu,T.,Mayrhofer,T.,etc.High-risk plaque detected on coronary CT angiography predicts acute coronary syndromes independent of significant stenosis in acute chest pain: Results from the ROMICAT-II trial[J].2014,64(7).
- [7]Maros?Ferencik,Thomas?Mayrhofer,Daniel O.?Bittner,etc.Use of High-Risk Coronary Atherosclerotic Plaque Detection for Risk Stratification of Patients With Stable Chest PainA Secondary Analysis of the PROMISE Randomized Clinical Trial[J].2018,3(2).
- [8]Rahman AM,Joneidi Jafari H,Jang IK,etc.Noninvasive assessment of plaque morphology and composition in culprit and stable lesions in acute coronary syndrome and stable lesions in stable angina by multidetector computed tomography.[J].2006,47(8).
- [9]Rinella, Mary E..Nonalcoholic Fatty Liver Disease A Systematic Review[J].2015,313(22).
- [10]Yoshikawa,J.,Fukuda,S.,Tanaka,A.,etc.Napkin-ring sign on coronary CT angiography for the prediction of acute coronary syndrome[J].2013,6(4).
- [11]Motoyama S,Sarai M,Harigaya H.Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome.[J].2009,54(1).
- [12]U L, Mathiesen,L E, Franzén,H, Aselius,etc.Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild/moderate abnormalities of liver transaminases.[J].2002,34(7).
- [13]Stephan D, Fihn,Julius M, Gardin,Jonathan, Abrams,etc.2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the[J].2012,126.
- [14]Naga Chalasani,Zobair Younossi,Joel E. Lavine,etc.The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases[J].2018,67(1).
- [15]Piepoli, Massimo F.,Hoes, Arno W.,Agewall, Stefan,etc.2016 European Guidelines on cardiovascular disease prevention in clinical practice[J].2016,37(29).
- [16]Puchner, Stefan B.,Lu, Michael T.,Mayrhofer, Thomas,etc.High-Risk Coronary Plaque at Coronary CT Angiography Is Associated with Nonalcoholic Fatty Liver Disease, Independent of Coronary Plaque and Stenosis Burden: Results from the ROMICAT II Trial[J].2015,274(3).
- [17].EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis[J].2015,63(1).
- [18]Francque, Sven M.,van der Graaff, Denise,Kwanten, Wilhelmus J..Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications[J].2016,65(2).
- [19]Donghee Kim,W. Ray Kim,Hwa Jung Kim,etc.Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States[J].2013,57(4).